In the studies of breast cancer cells, PTK6 has been reported to enhance EGF-induced cellular migration [13]–[15], [19], while overexpression of PTK6 was reported to increase cellular invasive potential by inducing epithelial mesenchymal translation (EMT) in prostate cancer cells [25]. This evidence concerns the gene EGF and prostate carcinoma.